30 Dec 2016 11:42
TR-1:NOTIFICATION OFMAJOR INTERESTIN SHARESi |
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are PROTEOMEΒ SCIENCESΒ PLC attached: ii | |
2 Reason for the notification (please tick the appropriate box or boxes): | |
An acquisition or disposal of voting rights | YES |
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |
An event changing the breakdown of voting rights | |
Other (please specify): | |
Β 3. Full name of person(s) subject to the VULPESΒ LIFE SCIENCES FUND notification obligation: iii VULPESΒ TESTUDOΒ FUND | |
Β 4. Full name of shareholder(s) (if different from 3.):iv | |
5. Date of the transaction and date on which the threshold is crossed or 28 DECEMBER 2016 reached: v | |
6. Date on which issuer notified: 29 DECEMBER 2016 | |
7. Threshold(s) that is/are crossed or reached: vi,Β vii 18% | |
Β
8. Notified details: | |||||||
A: Voting rights attached to shares viii,Β ix | |||||||
Class/type of shares Β if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | |||||
Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of Β voting rights x | |||
Direct | Direct xi | Indirect xii | Direct | Indirect | |||
GB0003104196 | Β Β 52,973,125 | Β Β 52,973,125 | Β Β 53,238,125 | Β Β 53,238,125 | Β 18.09% | ||
Β
B: Qualifying Financial Instruments | ||||
Resulting situation after the triggering transaction | ||||
Type of financial instrument | Expiration date xiii | Exercise/ Conversion Period xiv | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights |
Β
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||
Resulting situation after the triggering transaction | ||||||
Type of financial instrument | Exercise price | Expiration date xvii | Exercise/ Conversion period xviii | Number of voting rights instrument refers to | % of voting rights xix, xx | |
Nomin al | Delta | |||||
Β
Total (A+B+C) | |
Number of voting rights | Percentage of voting rights |
53,238,125 | 18.09% |
Β
Β
Β
Β
Β
Β Β Proxy Voting: | |
10. Name of the proxy holder: | |
11. Number of voting rights proxy holder will cease to hold: | |
12. Date on which proxy holder will cease to hold voting rights: | |
Β
Β
Β 13. Additional information: | Β executive.pa@proteomics.com |
14. Contact name: | Β Victoria Birse |
15. Contact telephone number: |
Β
Follow the stocks